TRU - CEO Resignation and Interim CEO Appointment

Truscreen Group Limited (NZX/ASX:TRU) announces that for personal reasons, CEO, Dr. Beata Edling has resigned effective immediately and will assist in the transition to an interim CEO in the coming weeks. Beata has personal commitments to family in Poland and will be available to assist TruScreen on a consulting basis to further the business in Poland and central Europe.

Beata first joined TruScreen in 2020 as Head of Medical Affairs and after the COVID pandemic was appointed CEO in October 2022. Under her leadership, TruScreen’s commercialisation has demonstrated solid growth, culminating in TruScreen’s technology being put on the National Guidelines of China’s CSCCP and COGA’s Blue Book, plus Vietnam’s MOH National Technical List and the recent Mexico’s Cofeperis approval for the Public health sector. Her contribution has set the foundation for the company’s further growth.

Beata goes with the best wishes and thanks from the board and her colleagues at TruScreen. We wish her well.

Mr Martin Dillon, who was CEO from 2013 to 2019, will be appointed Interim CEO. TruScreen’s key China business will report directly to the Chairman. Martin previously successfully established our global distribution network, launched the TruScreen Ultra2 device, knows the technology and is well known to distributors. Martin also managed the listing of TruScreen on the NZX in 2014.

Chairman, Tony Ho, commented:

“We support and respect Beata’s decision in light of her family commitments in Poland. With Martin stepping back in as Interim CEO, there will be minimal disruption to our ongoing business. Beata will provide whatever assistance required for a seamless transition.

The company has a live Rights Offer to shareholders in the market. This untimely event will not disrupt the company’s strategic business plans”.

This announcement has been approved by the Board.

Ends

•  CEO Resignation and Appointment of Interim CEO

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

PYS - PaySauce to announce F26 full year results on 27 May 2026
PEB - Draft LCD Proposes Medicare Coverage for Triage and Triage
MEL - Meridian Energy monthly operating report for April 2026
FBU - Sale of South Australian property
AIR - Air New Zealand market update
May 14th Morning Report
PEB - Pacific Edge Placement Increased to NZ$25.4 Million
Radius Care Reports Earnings Growth and 50% Higher Dividend
May 13th Morning Report
Pacific Edge launches capital raise of NZ$24 million